ABSTRACT
The right combination of drugs and surgical treatment can improve systolic function and prevent, attenuate, or reverse heart failure. Patient education and disease management programs can reduce hospitalizations. Optimal treatment for each patient is guided by a thorough evaluation and use of functional classification and disease staging systems.
Footnotes
↵* The author has indicated that he has received grant or research support from Acorn Cardiovascular corporation, and is a consultant for Novartis. This paper discusses therapies that are experimental or not approved by the US Food and Drug Administration for the use under discussion. Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the authors but are not peer-reviewed.
- Copyright © 2003 The Cleveland Clinic Foundation. All Rights Reserved.
Jump to section
Related Articles
Cited By...
- No citing articles found.